A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PAYS SEC filings page.
Paysign, Inc. (PAYS) reported $100.6M in revenue over the twelve months to Jun 30, 2026, up 46.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Paysign's growth is becoming more profitable and cash-generative, but expansion is financed mainly through operating liabilities rather than traditional debt.
The FY2025 scale-up coincided with operating margin reaching9.0% from1.8% , indicating that additional volume is reaching profit after overhead. Operating cash flow was$52.5M against net income of$7.6M , so reported cash generation was driven far more by balance-sheet flows than accounting earnings.
Gross margin reached
Long-term debt was only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Paysign, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Paysign, Inc. has an operating margin of 9.0%, meaning the company retains $9 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is up from 1.8% the prior year.
Paysign, Inc.'s revenue surged 40.5% year-over-year to $82.0M, reflecting rapid business expansion. This strong growth earns a score of 90/100.
Paysign, Inc. carries a low D/E ratio of 0.13, meaning only $0.13 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Paysign, Inc.'s current ratio of 1.11 is below the typical benchmark, resulting in a score of 24/100. However, the company holds substantial cash reserves (76% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.
Paysign, Inc. converts 62.5% of revenue into free cash flow ($51.2M). This strong cash generation earns a score of 99/100.
Paysign, Inc.'s ROE of 15.6% shows moderate profitability relative to equity, earning a score of 39/100. This is up from 12.5% the prior year.
Paysign, Inc. scores 2.85, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($867.8M) relative to total liabilities ($227.8M). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Paysign, Inc. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Paysign, Inc. generates $6.95 in operating cash flow ($52.5M OCF vs $7.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Paysign, Inc. generated $28.3M in revenue in Q2 2026. This represents an increase of 48.1% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.
Paysign, Inc.'s EBITDA was $9.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 162.8% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.
Paysign, Inc. reported $6.8M in net income in Q2 2026. This represents an increase of 386.9% from the same quarter a year earlier. Against the prior quarter it is up 24.2%.
Paysign, Inc. earned $0.11 per diluted share (EPS) in Q2 2026. This represents an increase of 450.0% from the same quarter a year earlier. Against the prior quarter it is up 22.2%.
Cash & Balance Sheet
Paysign, Inc. generated $1.2M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 66.5% from the same quarter a year earlier. Against the prior quarter it is down 93.6%.
Paysign, Inc. held $176.5M in cash against $3.6M in long-term debt as of Q2 2026, with $248.4M of liabilities due within a year.
Not reported for Q2 2026.
Margins & Returns
Paysign, Inc.'s gross margin was 63.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.6 percentage points.
Paysign, Inc.'s operating margin was 24.8% in Q2 2026, reflecting core business profitability. This is up 17.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Paysign, Inc.'s net profit margin was 23.9% in Q2 2026, showing the share of revenue converted to profit. This is up 16.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.5 percentage points.
Paysign, Inc.'s ROE was 11.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 7.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.
Capital Allocation
Paysign, Inc. spent $200K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. It is unchanged from the prior quarter.
Paysign, Inc. invested $103K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 19.7% from the same quarter a year earlier. Against the prior quarter it is down 61.3%.
Not reported for Q2 2026.
PAYS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.3M+48.1% | $28.0M+50.8% | $22.8M+45.8% | $21.6M+41.6% | $19.1M+33.1% | $18.6M+41.0% | $15.6M+14.0% | $15.3M+23.0% |
| Cost of Revenue | $10.4M+41.4% | $9.8M+42.2% | $9.6M+50.4% | $9.4M+39.3% | $7.3M+8.6% | $6.9M+10.5% | $6.4M-2.2% | $6.8M+11.8% |
| Gross Profit | $17.9M+52.2% | $18.2M+55.8% | $13.1M+42.6% | $12.2M+43.4% | $11.8M+55.0% | $11.7M+68.5% | $9.2M+28.8% | $8.5M+33.8% |
| SG&A Expenses | $8.5M+4.3% | $8.9M+20.5% | $9.1M+28.8% | $8.4M+34.7% | $8.2M+36.2% | $7.4M+25.2% | $7.0M+31.9% | $6.2M+32.4% |
| Operating Income | $7.0M+387.7% | $6.7M+167.9% | $1.9M+299.3% | $1.6M+129.3% | $1.4M+1043.9% | $2.5M+1063.4% | $464K-26.5% | $690K+16.8% |
| EBITDA | $9.4M+162.8% | $9.3M+116.9% | $4.1M+87.4% | $3.8M+67.3% | $3.6M+127.3% | $4.3M+317.3% | $2.2M+19.7% | $2.3M+37.9% |
| Income Tax | $1.1M+75.4% | $2.0M+205.2% | $1.1M+923.9% | $30K-43.3% | $655K+170.7% | $665K+305.8% | -$137K+96.8% | $54K-48.9% |
| Net Income | $6.8M+386.9% | $5.4M+110.3% | $1.4M-0.7% | $2.2M+54.2% | $1.4M+99.1% | $2.6M+736.7% | $1.4M-75.6% | $1.4M+30.5% |
| EPS (Basic) | $0.12+300.0% | $0.10+100.0% | $0.03+50.0% | $0.04+33.3% | $0.03+200.0% | $0.05+400.0% | $0.02-80.0% | $0.03+50.0% |
| EPS (Diluted) | $0.11+450.0% | $0.09+80.0% | $0.030.0% | $0.04+33.3% | $0.02+100.0% | $0.05 | $0.03-70.0% | $0.03+50.0% |
| Diluted Shares (Avg) | 62M+7.1% | 61M+10.7% | N/A | 62M+10.2% | 58M+3.6% | 55M | N/A | 56M+4.8% |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
PAYS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $317.0M+63.5% | $312.7M+52.5% | $276.3M+54.3% | $209.5M+25.5% | $193.9M+6.4% | $205.1M+18.6% | $179.0M+22.1% | $167.0M+50.1% |
| Current Assets | $283.0M+78.3% | $277.4M+65.9% | $240.1M+51.1% | $171.3M+16.1% | $158.7M-2.9% | $167.2M+8.0% | $158.8M+23.0% | $147.5M+49.2% |
| Cash & Equivalents | $176.5M+54.9% | $179.5M+61.0% | $165.0M+34.9% | $118.6M+7.2% | $113.9M-14.7% | $111.5M-3.3% | $122.3M+11.9% | $110.6M+25.7% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $103.2M+149.6% | $94.2M+80.4% | $72.2M+121.2% | $49.6M+51.4% | $41.3M+60.5% | $52.2M+47.3% | $32.6M+101.2% | $32.8M+350.6% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $4.5M0.0% | $4.5M-18.6% | $4.5M | $4.5M | $4.5M | $5.5M | $0 | N/A |
| Total Liabilities | $256.8M+69.3% | $257.7M+55.4% | $227.8M+53.3% | $163.8M+18.3% | $151.7M-2.4% | $165.8M+12.4% | $148.6M+21.7% | $138.5M+48.8% |
| Current Liabilities | $248.4M+73.4% | $248.1M+59.4% | $216.3M+48.1% | $152.1M+12.0% | $143.3M-6.2% | $155.7M+7.6% | $146.1M+22.6% | $135.9M+50.9% |
| Non-Current Liabilities | $8.4M+0.1% | $9.6M-5.5% | $11.4M+360.3% | $11.6M+347.2% | $8.4M+207.6% | $10.2M+259.4% | $2.5M-15.3% | $2.6M-14.0% |
| Long-Term Debt | $3.6M-41.9% | $4.6M-41.7% | $6.1M | $6.1M | $6.1M | $7.8M | $0 | N/A |
| Total Equity | $60.2M+42.5% | $55.0M+40.1% | $48.5M+59.3% | $45.8M+60.5% | $42.2M+57.2% | $39.3M+54.3% | $30.4M+24.3% | $28.5M+56.9% |
| Retained Earnings | $27.3M+137.1% | $20.5M+102.9% | $15.1M+100.3% | $13.7M+122.9% | $11.5M+143.8% | $10.1M+151.5% | $7.5M+102.8% | $6.2M+422.2% |
Not reported in any period shown, so not listed: Inventory.
PAYS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3M-64.4% | $18.8M+411.4% | $48.1M+236.0% | $6.8M+133.5% | $3.6M-82.3% | -$6.0M-173.2% | $14.3M-38.9% | -$20.2M-600.5% |
| Depreciation & Amortization | $2.3M+10.4% | $2.6M+46.4% | $2.2M+29.6% | $2.2M+39.9% | $2.1M+47.3% | $1.8M+40.0% | $1.7M+44.5% | $1.6M+49.8% |
| Stock-Based Compensation | $1.3M+31.2% | $1.3M+91.0% | N/A | $1.3M+120.7% | $954K+42.4% | $672K+1.3% | N/A | $573K-19.2% |
| Capital Expenditures | $103K+19.7% | $266K+238.8% | $591K+405.9% | $454K+271.6% | $86K-40.4% | $79K+52.8% | $117K+162.8% | $122K-8.4% |
| Free Cash Flow | $1.2M-66.5% | $18.5M+403.0% | $47.5M+234.6% | $6.3M+131.1% | $3.6M-82.6% | -$6.1M-174.6% | $14.2M-39.3% | -$20.3M-620.7% |
| Investing Cash Flow | -$1.4M+20.3% | -$2.1M+53.3% | -$1.7M+30.9% | -$2.2M+10.8% | -$1.8M+23.5% | -$4.4M-95.5% | -$2.4M-17.2% | -$2.4M-25.2% |
| Financing Cash Flow | -$2.9M-584.4% | -$2.2M-485.4% | $0+100.0% | $69K+119.4% | $592K+2364.7% | -$376K | -$135K | -$356K-136.8% |
| Share Buybacks | -$200K | $200K-46.9% | $0-100.0% | $0-100.0% | $0 | $376K | $135K | $360K+140.0% |
Not reported in any period shown, so not listed: Dividends Paid.
PAYS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.3%+1.7pp | 65.0%+2.1pp | 57.7%-1.3pp | 56.3%+0.7pp | 61.6%+8.7pp | 62.9%+10.3pp | 58.9%+6.8pp | 55.5%+4.5pp |
| Operating Margin | 24.8%+17.3pp | 23.8%+10.4pp | 8.2%+5.2pp | 7.3%+2.8pp | 7.5%+6.7pp | 13.4%+15.3pp | 3.0%-1.6pp | 4.5%-0.2pp |
| Net Margin | 23.9%+16.6pp | 19.4%+5.5pp | 6.0%-2.8pp | 10.3%+0.8pp | 7.3%+2.4pp | 13.9%+11.6pp | 8.8%-32.3pp | 9.4%+0.5pp |
| Return on Equity | 11.2%+7.9pp | 9.9%+3.3pp | 2.8%-1.7pp | 4.8%-0.2pp | 3.3%+0.7pp | 6.6%+5.4pp | 4.5%-18.4pp | 5.0%-1.0pp |
| Return on Assets | 2.1%+1.4pp | 1.7%+0.5pp | 0.5%-0.3pp | 1.1%+0.2pp | 0.7%+0.3pp | 1.3%+1.1pp | 0.8%-3.1pp | 0.9%-0.1pp |
| Current Ratio | 1.140.0x | 1.120.0x | 1.110.0x | 1.130.0x | 1.110.0x | 1.070.0x | 1.090.0x | 1.090.0x |
| Debt-to-Equity | 0.06-0.1x | 0.08-0.1x | 0.13+0.1x | 0.13-4.7x | 0.15-5.6x | 0.20-5.6x | 0.00-5.0x | 4.86-0.3x |
| Asset Turnover | 0.090.0x | 0.090.0x | 0.080.0x | 0.100.0x | 0.100.0x | 0.090.0x | 0.090.0x | 0.090.0x |
| FCF Margin | 4.2%-14.4pp | 66.0%+98.9pp | 208.7% | 29.2% | 18.6% | -32.9%-95.0pp | 91.0% | -133.0% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Paysign, Inc. PAYS | FY2025 | $82.0M | $7.6M | 9.2% | $867.8M | 65/100 |
| Tucows, Inc TCX | FY2025 | $390.3M | -$75.8M | -19.4% | $108.0M | 22/100 |
| Veritone, Inc. VERI | FY2025 | $92.2M | -$111.7M | N/A | $59.5M | 35/100 |
| Sangoma Technologies Corporation SANG | FY2025 | $236.7M | -$5.0M | -2.1% | $161.9M | 33/100 |
| ZenaTech, Inc. ZENA | FY2025 | N/A | -$45.2M | N/A | $117.3M | — |
| Airship AI Holdings, Inc. AISP | FY2025 | $15.3M | $29.3M | N/A | $78.9M | 31/100 |
Where Paysign, Inc. Ranks
Frequently Asked Questions
What is Paysign, Inc.'s annual revenue?
Paysign, Inc. (PAYS) reported $82.0M in total revenue for fiscal year 2025. This represents a 40.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Paysign, Inc.'s revenue growing?
Paysign, Inc. (PAYS) revenue grew by 40.5% year-over-year, from $58.4M to $82.0M in fiscal year 2025.
Is Paysign, Inc. profitable?
Yes, Paysign, Inc. (PAYS) reported a net income of $7.6M in fiscal year 2025, with a net profit margin of 9.2%.
What is Paysign, Inc.'s EBITDA?
Paysign, Inc. (PAYS) had EBITDA of $15.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Paysign, Inc. have?
As of fiscal year 2025, Paysign, Inc. (PAYS) had $165.0M in cash and equivalents against $6.1M in long-term debt.
What is Paysign, Inc.'s gross margin?
Paysign, Inc. (PAYS) had a gross margin of 59.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Paysign, Inc.'s operating margin?
Paysign, Inc. (PAYS) had an operating margin of 9.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Paysign, Inc.'s net profit margin?
Paysign, Inc. (PAYS) had a net profit margin of 9.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Paysign, Inc.'s return on equity (ROE)?
Paysign, Inc. (PAYS) has a return on equity of 15.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Paysign, Inc.'s free cash flow?
Paysign, Inc. (PAYS) generated $51.2M in free cash flow during fiscal year 2025. This represents a 127.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Paysign, Inc.'s operating cash flow?
Paysign, Inc. (PAYS) generated $52.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Paysign, Inc.'s total assets?
Paysign, Inc. (PAYS) had $276.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Paysign, Inc.'s capital expenditures?
Paysign, Inc. (PAYS) invested $1.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Paysign, Inc.'s current ratio?
Paysign, Inc. (PAYS) had a current ratio of 1.11 as of fiscal year 2025, which is considered adequate.
What is Paysign, Inc.'s debt-to-equity ratio?
Paysign, Inc. (PAYS) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Paysign, Inc.'s return on assets (ROA)?
Paysign, Inc. (PAYS) had a return on assets of 2.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Paysign, Inc.'s P/E ratio?
Paysign, Inc. (PAYS) trades at 55.0x earnings, its market capitalization divided by net income of $15.8M net income, trailing 12 months to June 30, 2026. The market capitalization is $867.8M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Paysign, Inc.'s price-to-sales ratio?
Paysign, Inc. (PAYS) trades at 8.6x sales, its market capitalization divided by revenue of $100.6M revenue, trailing 12 months to June 30, 2026. The market capitalization is $867.8M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Paysign, Inc.'s Altman Z-Score?
Paysign, Inc. (PAYS) has an Altman Z-Score of 2.85, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Paysign, Inc.'s Piotroski F-Score?
Paysign, Inc. (PAYS) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Paysign, Inc.'s earnings high quality?
Paysign, Inc. (PAYS) has an earnings quality ratio of 6.95x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Paysign, Inc.?
Paysign, Inc. (PAYS) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.